SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Property, Plant & Equipment (Net)

Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026

Property, plant & equipment (net) of $4.24M in Q1 FY2026

Q1 FY2026 property, plant & equipment (net) was $4.24M.

Context

  • Property, plant & equipment (net) amounted to 1.6% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.24M+8.8% QoQ
Last fiscal yearDec 2025
$3.89M— YoY
Property, Plant & Equipment (Net) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Property, Plant & Equipment (Net) history

USD · from the balance sheet

Latest · FY2025
3.89M USD
Year-over-year change
—

Property, Plant & Equipment (Net) vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
  • Property, plant & equipment (net) amounts to 1.6% of total assets for SGP, versus a peer median of 7.6%.
SGP Competitors
Property, Plant & Equipment (Net) for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$5.28B USD+2.6%+5.7%16.8%
BLCOBausch + Lomb CorporationJun 2026$1.8B USD+7.1%+7.5%13.0%
GKOSGlaukos CorporationJun 2026$181.58M USD-1.5%+3.4%19.7%
STAASTAAR Surgical CompanyApr 2026$100.31M USD-5.4%+8.1%22.2%
OCULOcular Therapeutix, Inc.Mar 2026$24.92M USD+50.0%+10.8%3.4%
RXSTRxSight, Inc.Mar 2026$22.99M USD-2.1%+17.8%7.6%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$19.78M USD-33.1%+39.8%6.9%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$4.24M USD——1.6%
OCSOculis Holding AGMar 2026CHF 2.86M CHF+80.7%+38.8%1.2%
SGHTSight Sciences, Inc.Mar 2026$2.82M USD+22.5%-13.7%2.6%
Peer median (excluding SGP) —+2.6%+8.1%7.6%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.